Ando ApS
Ando ascertains the IND/ CTA enabling pathway
By having the end in mind, Ando analyses scientific data, identifies the regulatory strategy and development programme required for the first clinical trial and supports its implementation.
By having the end in mind, Ando analyses scientific data, identifies the regulatory strategy and development programme required for the first clinical trial and supports its implementation.
allows Ando to serve its clients in a best possible and flexible way – just as required.
allows Ando to engage specific expertise & resources if needed.
Nordre Strandvej 119F
DK-3150 Hellebæk,
Denmark DK31612845
MOBILE: +45 2568 3668
EMAIL: anke.domdey@andobio.com